Paul T. Quinlan

Companies

• Oruka Therapeutics, Inc.General counsel Sep 6, 2024 to now¹
• CymaBay Therapeutics (United States)General counsel Dec 4, 2017 to Mar 22, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• OTOruka Therapeutics, Inc. ORKA29,995 shares³$2.3M at $75.38Sep 21, 2026
• CTCymaBay Therapeutics (United States)0 shares⁴Mar 22, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 21, 2026Sold 2,667 shares at $95.31 of Oruka Therapeutics, Inc.³
• Sep 21, 2026Sold 601 shares at $94.44 of Oruka Therapeutics, Inc.³
• Sep 21, 2026Sold 3,832 shares at $93.32 of Oruka Therapeutics, Inc.³
• Sep 21, 2026Sold 2,900 shares at $92.37 of Oruka Therapeutics, Inc.³
• Sep 21, 2026Exercised options 10,000 shares at $7.80 of Oruka Therapeutics, Inc.³
• Sep 15, 2026Sold 1,039 shares at $95.71 of Oruka Therapeutics, Inc.⁵
• Aug 14, 2026Sold 3,847 shares at $111.14 of Oruka Therapeutics, Inc.⁶
• Aug 14, 2026Sold 9,193 shares at $110.00 of Oruka Therapeutics, Inc.⁶
• Aug 14, 2026Sold 10,200 shares at $109.11 of Oruka Therapeutics, Inc.⁶
• Aug 14, 2026Sold 14,696 shares at $107.97 of Oruka Therapeutics, Inc.⁶
• Aug 14, 2026Sold 10,434 shares at $107.14 of Oruka Therapeutics, Inc.⁶
• Aug 14, 2026Sold 3,630 shares at $106.05 of Oruka Therapeutics, Inc.⁶
• Aug 14, 2026Exercised options 42,000 shares at $12.50 of Oruka Therapeutics, Inc.⁶
• Aug 14, 2026Exercised options 10,000 shares at $7.80 of Oruka Therapeutics, Inc.⁶
• Jun 15, 2026Sold 733 shares at $69.69 of Oruka Therapeutics, Inc.⁷
• Mar 16, 2026Sold 733 shares at $41.30 of Oruka Therapeutics, Inc.⁸
• Jan 23, 2026Granted 32,500 shares of Oruka Therapeutics, Inc.⁹
• Mar 22, 2024Returned to company 28,438 shares of CymaBay Therapeutics (United States)⁴
• Mar 22, 2024Returned to company 41,824 shares of CymaBay Therapeutics (United States)⁴
• Mar 13, 2024Exercised options 41,824 shares at $7.89 of CymaBay Therapeutics (United States)¹⁰
• Jan 24, 2024Granted 28,438 shares of CymaBay Therapeutics (United States)¹¹
• Jan 16, 2024Sold 5,000 shares at $23.58 of CymaBay Therapeutics (United States)¹²
• Jan 16, 2024Exercised options 5,000 shares at $2.94 of CymaBay Therapeutics (United States)¹²
• Dec 15, 2023Sold 5,000 shares at $21.98 of CymaBay Therapeutics (United States)¹³
• Dec 15, 2023Exercised options 5,000 shares at $2.94 of CymaBay Therapeutics (United States)¹³